Wholomics

Wholomics is developing a novel technique for early cancer detection and recognition of cancer-specific molecular signatures. These should not only help detecting cancer earlier but also to stratify patients into different classes, thus allowing more individualized treatment and therapy approaches. Wholomics is looking for partners who want to understand their patient groups better and personalize treatment to change the paradigm of medicine and improve lifes.

LEARN MORE

Websitewww.wholomics.comCountryAustriaTypeCompany

SUBSCRIBE TO OUR NEWSLETTER

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. This work was also partly supported by the Swiss State Secretariat for Education, Research, and Innovation (SERI) under contract No. 22.00115.